pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›adebrelimab
drug
save

adebrelimab

updated 5mo ago
by Jiangsu Hengrui Pharmaceuticals Co Ltd
community read0 votes

🐶 often sniffed alongside

top 6
  • tagOncology6 co-mentions · 3 sources
  • tagNSCLC3 co-mentions · 2 sources
  • tagPulmonology2 co-mentions · 2 sources
  • companyJiangsu Hengrui Pharmaceuticals Co Ltd1 co-mentions · 1 sources
  • companyHospital Of Dalian Medical University 11 co-mentions · 1 sources
  • companyNanfang Hospital of Southern Medical University1 co-mentions · 1 sources

all catalysts(3)

phase 1 2 completion · 1
Apr 30, 2026
phase 1 2 completion
5mo ago
Jiangsu Hengrui Pharmaceuticals Co Ltd — adebrelimab (Phase I/II Trial Completion)
adebrelimab
→
phase 2 completion · 2
Apr 30, 2026
phase 2 completion
5mo ago
Hospital Of Dalian Medical University 1 — adebrelimab (Phase II Trial Completion)
adebrelimab
→
Apr 30, 2026
phase 2 completion
5mo ago
Nanfang Hospital of Southern Medical University — adebrelimab (Phase II Trial Completion)
adebrelimab
→

Trials studying adebrelimab

  • phase2A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterationsnot yet recruitingn=76
  • phase2A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumorsrecruitingn=80
  • phase2Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancerrecruitingn=43
  • phase3A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinomanot yet recruitingn=690
  • phase2A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinomanot yet recruitingn=120
  • phase2A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumorsrecruitingn=156
  • phase2Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by TACE-HAICnot yet recruitingn=38
  • phase3Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancernot yet recruitingn=874

News(1)

  • GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
    We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.
    onclive · 4mo ago
Data sources
ClinicalTrials.gov
last refreshed 5h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?